FIELD: medicine, pharmaceutics.
SUBSTANCE: invention refers to medicine and cosmetology and can be used for the effective transdermal delivery of the wide range of active substances (AS). What is declared is a method for the transdermal delivery of the active substances as a part of PEG-12 dimethicone niosomes characterised by the fact that the AS are included into the niosomes in the concentration of 10% by homogenising gel containing 10% niosomes in the homogeniser APV.
EFFECT: invention provides the higher transdermal effect of the interstitial delivery of the AS as a part of the niosomes.
3 tbl, 2 dwg
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR MAKING TRANSDERMAL PATCH CONTAINING PEG-12 DIMETHICONE NIOSOMES | 2012 |
|
RU2539397C2 |
| DENTAL GEL HAVING NIOSOMES FOR TREATMENT OF INFLAMMATORY AND DYSTROPHIC PERIODONTAL DISEASES | 2013 |
|
RU2582290C2 |
| DOXORUBICIN AND ORGANOSILICON NANOPARTICLES-NIOSOMES- BASED PHARMACEUTICAL GEL FOR SKIN CANCER TREATING | 2014 |
|
RU2600164C2 |
| TRANSDERMAL ANTHELMINTIC AGENT OF SILICONE NIOSOMES WITH ALBENDAZOLE | 2013 |
|
RU2541156C1 |
| SYSTEM FOR DELIVERY OF BIOACTIVE SUBSTANCES BY USING NIOSOMES | 2006 |
|
RU2320323C1 |
| TRANSDERMAL GEL FOR AREA AROUND EYES "SILKY TOUCH" | 2007 |
|
RU2383328C2 |
| TRANSDERMAL GEL FOR FACE 'STVOLIN" | 2007 |
|
RU2376974C2 |
| REGENERIN SERUM FOR EXTERNAL APPLICATION WITH ANTI-INFLAMMATORY AND REGENERATIVE EFFECT | 2011 |
|
RU2469704C1 |
| PHARMACEUTICAL NIOSOMAL GEL BASED ON N-HYDROXY-2-(2-(NAPHTALENE-2-YL)-1H-INDOLE-3-YL)-2-PHENYLACETAMIDE WITH ANTI-TUMOUR ACTIVITY TO GLIOBLASTOMA | 2015 |
|
RU2627449C2 |
| MOISTENING SERUM FOR FACE "VITA" | 2007 |
|
RU2376982C2 |
